Targeted Oncology· @TargetedOnc · X·· 19 小时前评分45
正文 · 原文
At #ESMO26, Rahul Winayak, MD (@cityofhope) explains new metastatic #RCC targets—GPR65, HPK1, ENPP3, CD70—that aim to overcome #immunotherapy resistance.
🎥 WATCH: https://www.targetedonc.com/view/rahul-winayak-emerging-therapeutic-targets-metastatic-renal-cell-carcinoma
#KidneyCancer #Oncology | @RWinayak @CityofHope_GU
31 浏览 · 0 赞 · 0 转发 · 0 回复
来源：Targeted Oncology · x.com